Medical Oncologist and PhD candidate. Affiliated with Wollongong Hospital, and University of Sydney, 🇦🇺. Views my own.

Joined March 2012
4 Photos and videos
Lawrence Kasherman retweeted
🚨Our latest meta-analysis (1st of a 2-part series): - Pts in comprehensive #cancer centers (CCC) have 23% ↓ overall mortality risk compared to non-CCC - Mixed results re time to care/ #pallonc - Look out for our next article on CCCs worldwide Read here👉tinyurl.com/jhadn4ua
3
17
42
3,339
Lawrence Kasherman retweeted
Come and join me as I share reflections on the role of art in the practice of oncology. Excellent panel. Lots of food for thought. Bonus: it will also be a visual feast. #cosa2024
1
3
21
1,339
Lawrence Kasherman retweeted
#CancerSurvivorship We are looking forward to share our road map to ensure that AC2 is sustainable, with continued collaborations with our key stakeholders and to identify funding opportunities to continue advancing cancer survivorship care for people with Chinese backgrounds.
1
5
8
604
Lawrence Kasherman retweeted
Great summary of survivorship in Australia - practice and research - by Janette Vardy including opportunities to progress #AC2Forum @survonc
1
1
8
388
Lawrence Kasherman retweeted
After months of planning, we are finally kicking off the AC2 Leadership Forum today! AC2 is a project led by the Caring Futures Institute, Flinders University and our partners across Australia, and countries in the Asia-Pacific region. @AusCGHK
2
2
8
469
Great to be a part of the AC2 leaders forum in Hong Kong, working towards further collaborations in #CancerSurvivorship care for Chinese speaking populations #survonc @janette_vardy @drcarolynee @chitchadkitchen @rayychan
Replying to @survonc
This forum will drive pivotal conversations about improving cancer survivorship care for people with a Chinese background, through innovation and cross-cultural understanding. Special thanks to HKU for hosting and NFACR for their support! #AC2Forum #CancerSurvivorship
1
22
979
Lawrence Kasherman retweeted
Does belonging to multiple disadvantaged groups = worse health? 🤔 My review shows that it does. This is why clinical trials must address intersectionality if we are to properly tackle health inequalities. #ICTMC2024 #PhD #ClinicalTrials #Intersectionality
2
15
68
3,744
Lawrence Kasherman retweeted
Now, lets consider @Erman_Akkus points Point #1. Patients on the control arm get Atezo-Bev or Sorafenib or Lenva-Pembro when they progress, so this will 'affect' OS He has to backwards! You WANT them to get the best care, and you have to PROVE treating earlier is better!
1
1
21
9,303
Lawrence Kasherman retweeted
Concerned about time toxicity affecting your patients? Contribute to research on this topic by responding to a questionnaire at redcap.slhd.nsw.gov.au/surve…
5
10
684
Lawrence Kasherman retweeted
👀Seeking GP expertise to inform policies and health systems on how to support provision of cancer survivorship in primary care Developed by GPs, for GPs! To take part in our national survey please go to qualtrics.flinders.edu.au/jf… Thank you 🙏 @survonc @PC4TG @COSA_Surviv

6
9
2,311
Lawrence Kasherman retweeted
Join us this Friday, 🗓️30 August, 📷 ONLINE, 📷#CALD #chinese focused update on Intimacy Changes in Cancer Survivorship. Live translation in Mandarin too! Register using link: trybooking.com/events/landin…
1
7
14
2,075
Lawrence Kasherman retweeted
Congratulations @LKasherman winner of the young Onc oral prize! Fantastic research with @janette_vardy @Joanne472 @AshMalalasekera @CindyTa09878114 So great to be flying the flag for qualitative research in survivorship and with CALD populations! #MOGA24 @MOGA_ORG
1
2
18
440
Lawrence Kasherman retweeted
BMI >40 is equivalent as a LIFETIME risk factor for Endometrial cancer to smoking 5 cigs/day as a risk factor for Lung cancer - @ProfEmmaCrosbie's emphasis on the need for primary prevention in high-risk populations at #ASCO2024 This is a public health concern. @anzgog
1
8
20
1,281
Lawrence Kasherman retweeted
7 Jun 2024
Uterine (endometrial) cancer is a global issue. Connecting with other world leaders in research is critical to improving treatments and outcomes for women with gynaecological cancer across the world.
1
7
13
512
Lawrence Kasherman retweeted
A joint MASCC-ASCO initiative ➡️ new global standards & practice recs for the consistent provision of high quality #survivorship care to people with advanced or metastatic #cancer & their caregivers 👏 @JCOOP_ASCO @DrNicolasHart @rayychan @CancerCareMASCC thelimbic.com/oncology/new-g…
5
10
760
Lawrence Kasherman retweeted
🚨Survivorship Care for People affected by Advanced or Metastatic Cancer🚨 💥 MASCC-ASCO Standards / Practice Recommendations now published💥 ‼️ Clinical tools online ‼️ 14 languages (coming soon) Co-published open access: ascopubs.org/doi/full/10.120… and link.springer.com/article/10…
8
48
99
45,597
Lawrence Kasherman retweeted
Multicenter cohort of patients with stage IA p53 abnormal #endometrialcancer without myometrial invasion had 16% risk for recurrent disease with most having distant pattern of recurrence. ijgc.bmj.com/content/34/4/54… @IJGConline @DrAmyJamieson #gyncsm #gynonc
11
31
1,643
Lawrence Kasherman retweeted
Early Career Clinicians Workshop “Research is not complete until it’s published and presented” Dr Yeh Chen Lee “The importance of a mentor “to guide and DRAG you through” Dr Silipa Naiquiso * Mentors - we all need them, and also need to become them A/Prof Emma Allanson
1
6
14
1,038
Lawrence Kasherman retweeted
3 Apr 2024
11
16
1,917